John Harold Leaman

CIK 1586657 · Chief Fin. & Business Officer · last filed 2026-03-10

John Harold Leaman is a Chief Fin. & Business Officer who has filed 13 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for TRAW, was dated Mar 10, 2026. Current disclosed insider exposure totals $5.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.2K

Companies

4

Total Filings

13

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRAW Director 4,058 $1.28 $5.2K $0 4 2026-03-10
IPI Legacy Liquidation Co (IMPL) Delisted Chief Fin. & Business Officer 10,571 $0.24 $2.5K $0 5 2023-02-16
Cartesian Therapeutics, Inc. (SELB) Delisted CFO, Treas. & Hd Corp Strategy $0.88 $0 2 2018-06-19
Aevi Genomic Medicine, LLC (MDGN.WS) Delisted Chief Financial Officer $0 2 2015-02-20

Recent Filings

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-03-10 TRAW Grant (A) $0 EDGAR
2025-12-16 TRAW Grant (A) +4,058 $0 EDGAR
2025-11-25 TRAW Grant (A) $0 EDGAR
2025-10-14 TRAW Grant (A) $0 EDGAR
2023-02-16 IPI Legacy Liquidation Co (IMPL) Delisted Grant (A) $0 EDGAR
2023-01-04 IPI Legacy Liquidation Co (IMPL) Delisted Mixed +6,944 -$13.6K EDGAR
2022-01-28 IPI Legacy Liquidation Co (IMPL) Delisted Grant (A) $0 EDGAR
2021-10-21 IPI Legacy Liquidation Co (IMPL) Delisted Grant (A) $0 EDGAR
2021-07-26 IPI Legacy Liquidation Co (IMPL) Delisted Grant (A) $0 EDGAR
2018-06-19 Cartesian Therapeutics, Inc. (SELB) Delisted Grant (A) $0 EDGAR
Showing 110 of 13
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.